Contcenter for Genomic Regul

Total Page:16

File Type:pdf, Size:1020Kb

Contcenter for Genomic Regul CONTCENTER FOR GENOMIC REGUL CRG SCIENTIFIC STRUCTURE . 4 CRG MANAGEMENT STRUCTURE . 6 CRG SCIENTIFIC ADVISORY BOARD (SAB) . 8 CRG BUSINESS BOARD . 9 YEAR RETROSPECT BY THE DIRECTOR OF THE CRG: MIGUEL BEATO . 10 GENE REGULATION. 14 p Chromatin and gene expression .....................16 p Transcriptional regulation and chromatin remodelling .....19 p Regulation of alternative pre-mRNA splicing during cell . 22 differentiation, development and disease p RNA interference and chromatin regulation . 26 p RNA-protein interactions and regulation . 30 p Regulation of protein synthesis in eukaryotes . 33 p Translational control of gene expression . 36 DIFFERENTIATION AND CANCER ...........................40 p Hematopoietic differentiation and stem cell biology..........42 p Myogenesis.....................................46 p Epigenetics events in cancer.......................49 p Epithelial homeostasis and cancer ...................52 ENTSATION ANNUAL REPORT 2006 GENES AND DISEASE .................................56 p Genetic causes of disease .............................58 p Gene therapy ......................................63 p Murine models of disease .............................66 p Neurobehavioral phenotyping of mouse models of disease .....68 p Gene function ......................................73 p Associated Core Facility: Genotyping Unit..................76 BIOINFORMATICS AND GENOMICS ..........................80 p Bioinformatics and genomics ...........................82 p Genomic analysis of development and disease ..............86 p Associated Core Facility: Microarrays Unit.................88 CELL AND DEVELOPMENTAL BIOLOGY ........................90 p Microtubule function and cell division ....................92 p Sensory cell biology and organogenesis ..................96 SYSTEMS BIOLOGY ..................................100 p Design of biological systems..........................102 p Systems analysis of development .......................107 p Gene Network Engineering ............................111 p Metazoan Systems ..................................115 APPENDIX 1: ...........................................120 p V CRG Annual Symposium: “Systems Biology: A Cell in the Computer?” APPENDIX 2: ...........................................122 p CRG Seminars and Programme Seminars APPENDIX 3:............................................129 p Grants CRG SCIENTIFIC STRUCTURE BOARD OF TRUSTEES DIRECTOR Miguel Beato DEPUTY DIRECTOR Luis Serrano SCIENTIFIC SCIENTIFIC FACULTY BOARD EXECUTIVE BOARD BUSINESS BOARD ADVISORY BOARD COMMITTEE GENE BIONFORMATICS CELL AND SYSTEMS DIFFERENTIATION GENES REGULATION AND GENOMICS DEV. BIOLOGY BIOLOGY AND CANCER AND DISEASE MIGUEL BEATO RODERIC GUIGÓ ISABELLE VERNOS LUIS SERRANO THOMAS GRAF XAVIER ESTIVILL Coordinator Coordinator Acting Coordinator Coordinator Coordinator Coordinator MICROTUBULES CHROMATIN AND BIOINFORMATICS AND DESING OF HEMATOPOIETIC GENETIC CAUSES FUNCTION AND CELL GENE EXPRESSION GENOMICS BIOLOGICAL SYSTEMS DIFFERENTIATION AND OF DISEASE DIVISION RODERIC GUIGÓ STEM CELL BIOLOGY XAVIER ESTIVILL MIGUEL BEATO ISABELLE VERNOS LUIS SERRANO Group Leader THOMAS GRAF Group Leader Group Leader Group Leader Group Leader ............................... Group Leader TRANSCRIP. REGULATION FUNCTIONAL GENOMICS AND CHROMATIN OF NEUROLOGICAL DISORDERS REMODELLING GENOMIC ANALYSIS SENSORY CELL BIOLOGY SYSTEMS ANALYSIS EULÀLIA MARTÍ ALBERT JORDAN OF DEVELOPMENT AND AND ORGANOGENESIS OF DEVELOPMENT MYOGENESIS Staff Scientist Staff Scientist DISEASE HERNAN LOPEZ-SCHIER JAMES SHARPE PURA MUÑOZ LAURO SUMOY Group Leader Group Leader Group Leader Group Leader REGULATION OF ALTERNATIVE GENE THERAPY PRE-MRNA SPLICING CRISTINA FILLAT CORE FACILITY- JUAN VALCÁRCEL CORE FACILITY- GENE NETWORK EPIGENETICS EVENTS Group Leader MICROARRAYS UNIT Group Leader ADVANCED LIGHT ENGINEERING IN CANCER LAURO SUMOY MICROSCOPY UNIT MARK ISALAN LUCIANO DI CROCE Unit Leader (Under Construction) Group Leader Group Leader RNA INTERFERENCE AND MURINE MODELS CHROMATIN REGULATION OF DISEASE RAMIN SHIEKHATTAR EPITHELIAL HOMEOSTA- MARIONA ARBONÉS METAZOAN SYSTEMS Group Leader SIS AND CANCER Group Leader BEN LEHNER SALVADOR AZNAR-BENITAH Group Leader Group Leader TRANSLATIONAL CONTROL NEUROBEHAVIORAL PHENOTYPING OF OF GENE EXPRESSION MOUSE MODELS OF RAÚL MÉNDEZ DISEASE Group Leader CORE FACILITY- MARA DIERSSEN FACS UNIT Group Leader REGULATION OF PROTEIN SYNTHESIS GENE FUNCTION IN EUKARYOTES SUSANA DE LA LUNA FÁTIMA GEBAUER Group Leader Group Leader RNA-PROTEIN INTERAC- CORE FACILITY- TIONS AND REGULATION GENOTYPING UNIT JOSEP VILARDELL MÓNICA BAYÉS Group Leader Unit Responsible CORE FACILITY- PROTEOMICS UNIT (Under Construction) CRG MANAGEMENT STRUCTURE BOARD OF TRUSTEES DIRECTOR CEO MIGUEL BEATO MARIAN MARRODAN ASSISTANT ASSISTANT MONTSERRAT RODÓN CRISTINA CASAUS RESEARCH ORGANIZATION HUMAN GENERAL COMMUNICATION OFFICE, FINANCES TECHNOLOGY AND ICT RESOURCES / SERVICES AND PUBLIC AND GRANTS SCIENTIFIC TRANSFER MANAGEMENT LEGAL DEPARTMENT MANAGEMENT RELATIONS OFFICERS MANAGEMENT SILVIA TÓRTOLA EVA DEL PINTO ISABEL BELLOT CRISTINA CASAUS JOSEP QUERALT GLORIA LLIGADAS PROGRAMME HHRR-PERSONNEL PURCHASING AND RESEARCH OFFICE SECRETARIES AND LOGISTICS GENETIC CAUSES CLARA LÓPEZ MAGALÍ BARTOMEUS COLLABORATORS SERGI REPULLO OF DISEASE MANAGEMENT MARIBEL CORRAL EVA IBÁNEZ MIREIA PÉREZ ÀUREA RODRÍGUEZ GLORIA FREIXAS GEMMA PÉREZ MONTSERRAT ESTAPÉ IMMA FALERO VERONICA JAREÑO BLANKA WYSOCKA NICOLA COLLU DESIGN OF ACCOUNTING HHRR-FELLOWSHIP BIOLOGICAL AND TECHNICAL OWNERS AND SYSTEMS SCIENTIFIC STUDENTS MANAGEMENT MICHELA BERTERO SERVICES RECEPTION / ENRIC GUMMÀ ADMINISTRATIVE MARIBEL DAVID MAINTENANCE SUPPORT MARÍA ROZAS JOSEP QUERALT SONIA PARAREDA JAUME BACARDIT SASCHA ANDREU BÁRBARA FERREIRA HHRR-SUPPORT ESTHER SALAS CONTROL AND WORKING RISKS / PROJECTS RADIOACTIVITY / MANAGEMENT JUSTIFICATON WASTES MARTA MOLINA SYSTEMS Outsourcing SONIA ALCÁZAR ÓSCAR FRAILE MªJOSÉ ROMA JAUME BACARDIT LEGAL ENRIC GUMMÀ DEPARTMENT EVA DEL PINTO CRISTINA CASAUS SYSTEMS ADMINISTRATION EiPMC AND SUPPORT SERVICE ARANTXA VENTURA Outsourcing CRG SCIENTIFIC ADVISORY BOARD (SAB) DR. KAI SIMONS (chairman) Max Planck Institute of Molecular Cell Biology and Genetics, Dresden DR. STYLIANOS EMMANUEL ANTONARAKIS Medical Genetics, University of Geneva, Geneva DR. MICHAEL ASHBURNER European Bioinformatics Institute-EMBL Outstation, Department of Genetics, University of Cambridge, Cambridge DR. PIERRE CHAMBON Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Strasbourg DR. IAIN MATTAJ European Molecular Biology Laboratory (EMBL), Heidelberg DR. JOAN MODOLELL Center of Molecular Biology “Severo Ochoa”, CSIC & Autonomous University of Madrid, Madrid DR. ARNOLD MUNNICH Det. Génétique, Hôpital des Enfants Malades, Paris DR. CHRISTIANE NÜSSLEIN-VOLHARD Abt. Genetik, Max Planck Institut für Entwicklungsbiologie, Tübingen DR. MARC VIDAL Dana Farber Cancer Institute, Boston, USA DR. ERWIN WAGNER Research Institute of Molecular Pathology (IMP), Vienna CRG BUSINESS BOARD PRESIDENT DR. ANTONI ESTEVE President, Esteve VICE-PRESIDENTS DR. JOSEP PROUS, JR. Executive Vice President, Prous Science SR. FERNANDO TURRÓ General Manager, Contratas y Obras MEMBERS SR. JESÚS ACEBILLO President, Novartis Farmacéutica, S.A. SR. RAFAEL BENJUMEA CABEZA DE VACA General Manager, Fundación Marcelino Botín DR. PERE BERGA R+D Management Director, Almirall Prodesfarma, S.A. SR. ANTONI GELONCH Corporate Social Responsibility Director, Sanofi-Aventis, S.A. and General Manager of the Aventis Foundation DR. GONZALO HERNÁNDEZ HERRERO Medical Director, Pfizer España, S.A. SR. RAFAEL PARDO AVELLANEDA General Manager, Fundación BBVA SR. JORDI RAMENTOL General Manager, Grupo Ferrer Internacional, S.A. SR. NARCÍS SERRA President, Caixa Catalunya (Grupo) YEAR RETROSPECT by the Director of CRG: Miguel Beato The past year has been dominated by the moving to the new building of the PRBB. Although new groups started to work in the new building during the summer, the majority of the new and established groups moved betwe- en October and December. By the end of the year only the Genotyping Facility and the Microarray Unit were still in the CMIMA building, waiting for the installation of appropriate spaces in the PRBB building. Another important event was the official signature of the partnership agreement with the European Molecular Biology Laboratory (EMBL), for the creation of an EMBL-CRG Research Unit in Systems Biology. The presenta- tion to the media took place on September 7. The agreement foresees financing of four independent research groups for a period of 9 years sub- jected to periodic evaluations. The Unit will be directed by Luis Serrano, the coordinator of the CRG Systems Biology programme. These important events took place in the context of a crisis in the coali- tion of political parties in power that lead to the outing from the Catalan Government of the Minister in charge of Research. Until the foreseen elec- tions in November, a provisional government was named with changes in the research competences. Under these conditions it was not possible to secure a finance planning for the next years despite a personal engage- ment of the President of the Generalitat. Nevertheless we have managed to go on with our roadmap and, after long rounds of interviews, we have recruited six new group leaders and a unit leader, five of them foreigners. The increasing number of groups and units has imposed a new organiza- tion of the leading structure. The former Direction Committee has split
Recommended publications
  • Applied Category Theory for Genomics – an Initiative
    Applied Category Theory for Genomics { An Initiative Yanying Wu1,2 1Centre for Neural Circuits and Behaviour, University of Oxford, UK 2Department of Physiology, Anatomy and Genetics, University of Oxford, UK 06 Sept, 2020 Abstract The ultimate secret of all lives on earth is hidden in their genomes { a totality of DNA sequences. We currently know the whole genome sequence of many organisms, while our understanding of the genome architecture on a systematic level remains rudimentary. Applied category theory opens a promising way to integrate the humongous amount of heterogeneous informations in genomics, to advance our knowledge regarding genome organization, and to provide us with a deep and holistic view of our own genomes. In this work we explain why applied category theory carries such a hope, and we move on to show how it could actually do so, albeit in baby steps. The manuscript intends to be readable to both mathematicians and biologists, therefore no prior knowledge is required from either side. arXiv:2009.02822v1 [q-bio.GN] 6 Sep 2020 1 Introduction DNA, the genetic material of all living beings on this planet, holds the secret of life. The complete set of DNA sequences in an organism constitutes its genome { the blueprint and instruction manual of that organism, be it a human or fly [1]. Therefore, genomics, which studies the contents and meaning of genomes, has been standing in the central stage of scientific research since its birth. The twentieth century witnessed three milestones of genomics research [1]. It began with the discovery of Mendel's laws of inheritance [2], sparked a climax in the middle with the reveal of DNA double helix structure [3], and ended with the accomplishment of a first draft of complete human genome sequences [4].
    [Show full text]
  • Gene Prediction: the End of the Beginning Comment Colin Semple
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by PubMed Central http://genomebiology.com/2000/1/2/reports/4012.1 Meeting report Gene prediction: the end of the beginning comment Colin Semple Address: Department of Medical Sciences, Molecular Medicine Centre, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK. E-mail: [email protected] Published: 28 July 2000 reviews Genome Biology 2000, 1(2):reports4012.1–4012.3 The electronic version of this article is the complete one and can be found online at http://genomebiology.com/2000/1/2/reports/4012 © GenomeBiology.com (Print ISSN 1465-6906; Online ISSN 1465-6914) Reducing genomes to genes reports A report from the conference entitled Genome Based Gene All ab initio gene prediction programs have to balance sensi- Structure Determination, Hinxton, UK, 1-2 June, 2000, tivity against accuracy. It is often only possible to detect all organised by the European Bioinformatics Institute (EBI). the real exons present in a sequence at the expense of detect- ing many false ones. Alternatively, one may accept only pre- dictions scoring above a more stringent threshold but lose The draft sequence of the human genome will become avail- those real exons that have lower scores. The trick is to try and able later this year. For some time now it has been accepted increase accuracy without any large loss of sensitivity; this deposited research that this will mark a beginning rather than an end. A vast can be done by comparing the prediction with additional, amount of work will remain to be done, from detailing independent evidence.
    [Show full text]
  • Meeting Review: Bioinformatics and Medicine – from Molecules To
    Comparative and Functional Genomics Comp Funct Genom 2002; 3: 270–276. Published online 9 May 2002 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/cfg.178 Feature Meeting Review: Bioinformatics And Medicine – From molecules to humans, virtual and real Hinxton Hall Conference Centre, Genome Campus, Hinxton, Cambridge, UK – April 5th–7th Roslin Russell* MRC UK HGMP Resource Centre, Genome Campus, Hinxton, Cambridge CB10 1SB, UK *Correspondence to: Abstract MRC UK HGMP Resource Centre, Genome Campus, The Industrialization Workshop Series aims to promote and discuss integration, automa- Hinxton, Cambridge CB10 1SB, tion, simulation, quality, availability and standards in the high-throughput life sciences. UK. The main issues addressed being the transformation of bioinformatics and bioinformatics- based drug design into a robust discipline in industry, the government, research institutes and academia. The latest workshop emphasized the influence of the post-genomic era on medicine and healthcare with reference to advanced biological systems modeling and simulation, protein structure research, protein-protein interactions, metabolism and physiology. Speakers included Michael Ashburner, Kenneth Buetow, Francois Cambien, Cyrus Chothia, Jean Garnier, Francois Iris, Matthias Mann, Maya Natarajan, Peter Murray-Rust, Richard Mushlin, Barry Robson, David Rubin, Kosta Steliou, John Todd, Janet Thornton, Pim van der Eijk, Michael Vieth and Richard Ward. Copyright # 2002 John Wiley & Sons, Ltd. Received: 22 April 2002 Keywords: bioinformatics;
    [Show full text]
  • Fatty-Acid Binding Proteins Modulate Sleep and Enhance Long-Term Memory Consolidation in Drosophila Jason R
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2011 Fatty-acid binding proteins modulate sleep and enhance long-term memory consolidation in Drosophila Jason R. Gerstner University of Wisconsin - Madison William M. Vanderheyden Washington University School of Medicine in St. Louis Paul J. Shaw Washington University School of Medicine in St. Louis Charles F. Landry Scarab Genomics Jerry C. P. Yin University of Wisconsin - Madison Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Part of the Medicine and Health Sciences Commons Recommended Citation Gerstner, Jason R.; Vanderheyden, William M.; Shaw, Paul J.; Landry, Charles F.; and Yin, Jerry C. P., ,"Fatty-acid binding proteins modulate sleep and enhance long-term memory consolidation in Drosophila." PLoS One.,. e15890. (2011). https://digitalcommons.wustl.edu/open_access_pubs/510 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Fatty-Acid Binding Proteins Modulate Sleep and Enhance Long-Term Memory Consolidation in Drosophila Jason R. Gerstner1*¤, William M. Vanderheyden2, Paul J. Shaw2, Charles F. Landry3, Jerry C. P. Yin1,4,5* 1 Department of Genetics, University of Wisconsin-Madison, Madison, Wisconsin, United States of America, 2 Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri, United States of America, 3 Scarab Genomics, LLC, Madison, Wisconsin, United States of America, 4 Department of Neurology, University of Wisconsin-Madison, Madison, Wisconsin, United States of America, 5 Waisman Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America Abstract Sleep is thought to be important for memory consolidation, since sleep deprivation has been shown to interfere with memory processing.
    [Show full text]
  • 2018 Ibangs Meeting: the 20Th Annual Genes, Brain & Behavior Meeting
    5/25/2018 Program for Thursday, May 17th 2018 IBANGS MEETING: THE 20TH ANNUAL GENES, BRAIN & BEHAVIOR MEETING WELCOME PROGRAM INDEXES PROGRAM FOR THURSDAY, MAY 17TH Days: next day all days View: session overview talk overview 08:30-16:00 Session FV: Pre-IBANGS Satellite Meeting, Functional Validation for Neurogenetics Location: Phillips Hall in the Siebens building room 1-11. The Siebens building is located at the Downtown Mayo Clinic Campus (not the Mayo Civic Center). Description:The transformative nature of next generation sequencing has changed how neuroscientists approach genomic sequence variation. Highly multiplexed molecular testing is providing an expanded level of information from which to make informed phenotypic predictions. The importance of this is reflected in the unprecedented expansion of genomic testing to determine the basis of neurologic conditions. Genomic testing results in many instances provide a definitive basis of a neurologic condition. However, in almost a high proportion of cases, the genomic sequencing results are confounded by the ambiguity of variants with uncertain clinical significance. Herein lies the key with which institutions will lead in the area of genomic medicine. There exists a critical need to provide a mechanism by which uncertain findings can be functionally characterized and translated into clinically actionable results. It is within thisr ealm that academic societies such as IBANGS can have a substantial and informative role on the future of clinical research and practice. This symposium will introduce the challenges and opportunities that exist in the field of human clinical neurogenetics and follow this with presentations of active work in the field of functional genetic finding validation for neurogenetics with a look to the future of genomic neurogenetics.
    [Show full text]
  • 2013 BGA Marseille
    2 Behavior Genetics Association The purpose of the Behavior Genetics Association is to promote the scientific study of the interrelationship of genetic mechanisms and behavior, both human and animal; to encourage and aid the education and training of research workers in the field of behavior genetics; and to aid in the dissemination and interpretation to the general public of knowledge concerning the interrelationship of genetics and behavior, and its implications for health and human development and education. For additional information about the Behavior Genetics Association, please contact the Secretary, Valerie Knopik ([email protected]) or visit the website (www.bga.org). EXECUTIVE COMMITTEE Position 2012-2013 2013-2014 President Eric Turkheimer Carol Prescott President-Elect Carol Prescott Paul Lichtenstein Past President Michael Pogue-Geile Eric Turkheimer Secretary Arpana Agrawal Valerie Knopik Treasurer Soo Rhee Soo Rhee Member-at-Large Marleen de Moor Marleen de Moor Member-at-Large Benjamin Neale Benjamin Neale Member-at-Large Tim Bates Matthew Keller 2013 MEETING INFORMATION The 43rd Annual Meeting of the Behavior Genetics Association is being held at Campus Saint Charles Aix Marseille University. Scientific sessions will occur throughout the day June 29 – July 2. The Opening Reception will be in the Garden in front of Amphi Mathématiques Physique (Building 9) from 18:00 to 21:00 on Friday, June 28. The Conference Banquet and Awards Ceremony will be held Monday, July 1 at Fort Ganteaume, beginning with cocktails at 18:30. A Festschrift for Professor Norman Henderson will be held on Tuesday, July 2 in Amphi Mathématiques Physique. Local Hosts: Michèle Carlier and Pierre Roubertoux We thank the following generous contributors to the 2013 student bursaries: Anonymous o Jenae Neiderhiser o Sally Manson Anderson o Michael Pogue-Geile o Timothy Bates o Chandra Reynolds o Norman Henderson o Michael Stallings o Kelly Klump o James R.
    [Show full text]
  • Regulation of Learning by Epha Receptors: a Protein Targeting Study
    The Journal of Neuroscience, November 1, 1999, 19(21):9538–9549 Regulation of Learning by EphA Receptors: a Protein Targeting Study R. Gerlai,1 N. Shinsky,1 A. Shih,1 P. Williams,2 J. Winer,2 M. Armanini,1 B. Cairns,3 J. Winslow,1 W.-Q. Gao,1 and H. S. Phillips1 Genentech, Inc., Departments of 1Neuroscience, 2Research BioAssay, and 3Pathology, South San Francisco, California 94080 EphA family receptor tyrosine kinases and their ephrin-A li- spontaneous alternation and context-dependent fear condi- gands are involved in patterning axonal connections during tioning, sensitive to hippocampal function, whereas activation brain development, but until now a role for these molecules in of EphA by infusion of an agonist immunoadhesin results in the mature brain had not been elucidated. Here, we show that enhanced performance on these tasks. Because the two be- both the EphA5 receptor and its ephrin-A ligands (2 and 5) are havioral tasks have different motivational, perceptual, and mo- expressed in the adult mouse hippocampus, and the EphA5 tor requirements, we infer the changes were not caused by protein is present in a phosphorylated form. Because there are these performance factors but rather to cognitive alterations. no pharmacological agents available for EphA receptors, we We also find bidirectional changes in gene expression and in designed recombinant immunoadhesins that specifically bind electrophysiological measures of synaptic efficacy that corre- to the receptor binding site of the ephrin-A ligand (antagonist) late with the behavioral results. Thus, EphA receptors and their or the ligand binding site of the EphA receptor (agonist) and ligands are implicated as mediators of plasticity in the adult thus target EphA function.
    [Show full text]
  • The Ethos and Effects of Data-Sharing Rules: Examining The
    Informed consent for: "The ethos and effects of data-sharing rules: Examining the history of the 'Bermuda principles' and their effects on 21 st century science" University of Adelaide Duke University Researchers at the University of Adelaide, Australia, and the IGSP Center for Genome Ethics, Law & Policy, Duke University, are engaged in research on the Bermuda Principles for sharing DNA sequence data from high-volume sequencing centers. You have been selected for an interview because we believe that the recollections you may have of your experiences with the International Strategy Meetings for Human Genome Sequencing (1996-1998) will be interesting and helpful for our project. We expect that interviews will last from 30 minutes to much longer, but you may stop your interview at any time. Your participation is strictly voluntary, and you do not have to answer every question asked. Your interview is being recorded and we may take written notes during the interview. After your interview, we may prepare a typed transcript of the interview. If we prepare a transcript, you will have an opportunity to review it and to make deletions and corrections. Unless you indicate otherwise, the information that you provide in this interview will be "on the record"-that is, it can be attributed to you in the various articles and chapters that we plan to write, and thus could become public through these channels. Jf, however, at some point in the interview you want to provide us with information that might be useful for us to know, but which you do not want to have attributed to you, you should tell us that you wish to go "off the record" and we will stop the recording.
    [Show full text]
  • Reproducibility of Behavioral Phenotypes in Mouse Models - a Short History with Critical and Practical Notes
    Reproducibility of behavioral phenotypes in mouse models - a short history with critical and practical notes Vootele Voikar Neuroscience Center and Laboratory Animal Center, Helsinki Institute of Life Science Correspondence: Mustialankatu 1 G Helsinki, Finland [email protected] Progress in pre-clinical research is built on endorsed by more than 1000 journals so far, reproducible findings, yet reproducibility has awareness of researchers and the quality of different dimensions and even meanings. Indeed, publications have not been sufficiently improved the terms reproducibility, repeatability, and (13-15). In order to facilitate and enhance replicability are often used interchangeably, implementation of the ARRIVE guidelines, a although each has a distinct definition. Moreover, revised version with exhaustive explanation and reproducibility can be discussed at the level of elaborative documentation was recently published methods, analysis, results, or conclusions (1, 2). (16, 17). Despite these differences in definitions and Paradigm shift. Mice and rats are the most dimensions, the main aim for an individual widely used model animals in basic biomedicine. research group is the ability to develop new However, there has been a drastic change in the studies and hypotheses based on firm and reliable relative use of these two rodent species over time findings from previous experiments. In practice (Figure 1). Historically, the rat was the model of this wish is often difficult to accomplish. In this choice for behavioral studies but from the review, issues affecting reproducibility in the field beginning of 1990s a sharp shift from rats to mice of mouse behavioral phenotyping are discussed. took place. Obviously, this was due to rapid Crisis in reproducibility.
    [Show full text]
  • Machine Learning, Optimization, and Data Science 6Th International Conference, LOD 2020 Siena, Italy, July 19–23, 2020 Revised Selected Papers, Part II
    Lecture Notes in Computer Science 12566 Founding Editors Gerhard Goos Karlsruhe Institute of Technology, Karlsruhe, Germany Juris Hartmanis Cornell University, Ithaca, NY, USA Editorial Board Members Elisa Bertino Purdue University, West Lafayette, IN, USA Wen Gao Peking University, Beijing, China Bernhard Steffen TU Dortmund University, Dortmund, Germany Gerhard Woeginger RWTH Aachen, Aachen, Germany Moti Yung Columbia University, New York, NY, USA More information about this subseries at http://www.springer.com/series/7409 Giuseppe Nicosia • Varun Ojha • Emanuele La Malfa • Giorgio Jansen • Vincenzo Sciacca • Panos Pardalos • Giovanni Giuffrida • Renato Umeton (Eds.) Machine Learning, Optimization, and Data Science 6th International Conference, LOD 2020 Siena, Italy, July 19–23, 2020 Revised Selected Papers, Part II 123 Editors Giuseppe Nicosia Varun Ojha University of Catania University of Reading Catania, Italy Reading, UK Emanuele La Malfa Giorgio Jansen University of Oxford University of Cambridge Oxford, UK Cambridge, UK Vincenzo Sciacca Panos Pardalos ALMAWAVE University of Florida Rome, Italy Gainesville, FL, USA Giovanni Giuffrida Renato Umeton University of Catania Harvard University Catania, Italy Cambridge, MA, USA ISSN 0302-9743 ISSN 1611-3349 (electronic) Lecture Notes in Computer Science ISBN 978-3-030-64579-3 ISBN 978-3-030-64580-9 (eBook) https://doi.org/10.1007/978-3-030-64580-9 LNCS Sublibrary: SL3 – Information Systems and Applications, incl. Internet/Web, and HCI © Springer Nature Switzerland AG 2020 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed.
    [Show full text]
  • Concepts, Historical Milestones and the Central Place of Bioinformatics in Modern Biology: a European Perspective
    1 Concepts, Historical Milestones and the Central Place of Bioinformatics in Modern Biology: A European Perspective Attwood, T.K.1, Gisel, A.2, Eriksson, N-E.3 and Bongcam-Rudloff, E.4 1Faculty of Life Sciences & School of Computer Science, University of Manchester 2Institute for Biomedical Technologies, CNR 3Uppsala Biomedical Centre (BMC), University of Uppsala 4Department of Animal Breeding and Genetics, Swedish University of Agricultural Sciences 1UK 2Italy 3,4Sweden 1. Introduction The origins of bioinformatics, both as a term and as a discipline, are difficult to pinpoint. The expression was used as early as 1977 by Dutch theoretical biologist Paulien Hogeweg when she described her main field of research as bioinformatics, and established a bioinformatics group at the University of Utrecht (Hogeweg, 1978; Hogeweg & Hesper, 1978). Nevertheless, the term had little traction in the community for at least another decade. In Europe, the turning point seems to have been circa 1990, with the planning of the “Bioinformatics in the 90s” conference, which was held in Maastricht in 1991. At this time, the National Center for Biotechnology Information (NCBI) had been newly established in the United States of America (USA) (Benson et al., 1990). Despite this, there was still a sense that the nation lacked a “long-term biology ‘informatics’ strategy”, particularly regarding postdoctoral interdisciplinary training in computer science and molecular biology (Smith, 1990). Interestingly, Smith spoke here of ‘biology informatics’, not bioinformatics; and the NCBI was a ‘center for biotechnology information’, not a bioinformatics centre. The discipline itself ultimately grew organically from the needs of researchers to access and analyse (primarily biomedical) data, which appeared to be accumulating at alarming rates simultaneously in different parts of the world.
    [Show full text]
  • Computational Biology: Plus C'est La Même Chose, Plus Ça Change
    Computational biology: plus c'est la même chose, plus ça change The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Huttenhower, Curtis. 2011. Computational biology: plus c'est la même chose, plus ça change. Genome Biology 12(8): 307. Published Version doi:10.1186/gb-2011-12-8-307 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:10576037 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Huttenhower Genome Biology 2011, 12:307 http://genomebiology.com/2011/12/8/307 MEETING REPORT Computational biology: plus c’est la même chose, plus ça change Curtis Huttenhower* The data deluge: still keeping our heads above water Abstract Bioinformatics has been dealing with an exponential A report on the joint 19th Annual International growth in data since its coalescence as a field in the Conference on Intelligent Systems for Molecular 1980s, making the Senior Scientist Award keynote with Biology (ISMB)/10th Annual European Conference which Michael Ashburner closed the conference on Computational Biology (ECCB) meetings and particularly appropriate. This retrospective by the ‘father the 7th International Society for Computational of ontologies in biology’, to quote the introduction by Biology Student Council Symposium, Vienna, Austria, ISCB president Burkhard Rost, detailed the remarkable 15‑19 July 2011. expansion of computational biology since Ashburner’s start as a Cambridge undergraduate 50 years ago.
    [Show full text]